Medtech investor Clearbridge Health plans Catalist IPO
It expects operating expenses to go up in the near term after IPO, and can't be certain that it will achieve profitability
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
CLEARBRIDGE Health, the medtech investor formerly known as Clearbridge Accelerator, is planning an initial public offering (IPO) on the Singapore Exchange.
Clearbridge Health, which was renamed in April, lodged a draft prospectus for a listing on the Catalist board last Friday.
Copyright SPH Media. All rights reserved.
TRENDING NOW
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Beijing’s calculated silence on the Iran war
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Vietnam formalises new state leadership, redefining ‘four pillars’ power balance
